MGRX icon

Mangoceuticals
MGRX

11 hedge funds and large institutions have $820K invested in Mangoceuticals in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

2.65% less ownership

Funds ownership: 2.65% → 0% (-2.6%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$135K
2
+$62.4K
3
+$41.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$20.6K
5
SS
Sunbelt Securities
Texas
+$15.3K

Top Sellers

1
-$47.1K
2
-$16.1K
3
-$2.81K
4
UBS Group
UBS Group
Switzerland
-$177
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$420K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$193K
ACA
3
Ackerman Capital Advisors
Texas
$75.6K
XT
4
XTX Topco
Cayman Islands
$62.4K
Northern Trust
5
Northern Trust
Illinois
$41.5K
SS
6
Sunbelt Securities
Texas
$15.3K
Osaic Holdings
7
Osaic Holdings
Arizona
$6.09K
SPIA
8
Steward Partners Investment Advisory
New York
$4.59K
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$1K
Bank of America
10
Bank of America
North Carolina
$386
UBS Group
11
UBS Group
Switzerland
$7
Renaissance Technologies
12
Renaissance Technologies
New York
–
Goldman Sachs
13
Goldman Sachs
New York
–
TRCT
14
Tower Research Capital (TRC)
New York
–